Hansamed Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HANSAMED INC, and what generic and branded alternatives to HANSAMED INC drugs are available?
HANSAMED INC has two approved drugs.
Summary for Hansamed Inc
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Hansamed Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hansamed Inc | ULTACAN | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 201751-001 | Jul 11, 2017 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Hansamed Inc | ULTACAN FORTE | articaine hydrochloride; epinephrine bitartrate | INJECTABLE;INJECTION | 201750-001 | Jul 11, 2017 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
